Leaflet: information for the user
Amisulpride Aurovitas 100 mg tablets EFG
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
1. What isAmisulpride Aurovitasand what it is used for
2. What you need to know before you start takingAmisulpride Aurovitas
3. How to takeAmisulpride Aurovitas
4. Possible side effects
5. Storage ofAmisulpride Aurovitas
6. Contents of the pack and additional information
Amisulprida Aurovitas contains an active ingredient called amisulpride. It belongs to a group of medicines known as antipsychotics.
It is used to treat a condition called schizophrenia, which may cause you to see, feel, or hear things that do not exist (hallucinations), have strange and frightening thoughts (delusions), change your behavior, and make you feel lonely. Sometimes, people with these symptoms may also feel tense, anxious, become suspicious or aggressive without apparent reason (known as 'positive symptoms'), or become depressed and withdrawn (known as 'negative symptoms').
Amisulprida works by improving these altered thoughts, feelings, and behaviors. It is used to treat schizophrenia in its early stages and also over the long term.
Do not take Amisulprida Aurovitas:
Do not take this medicine if you are affected by any of the above points. If you are unsure, speak with your doctor or pharmacist before taking Amisulprida Aurovitas.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Amisulprida Aurovitas.
Speak with your doctor or pharmacist before taking this medicine if:
If you are unsure whether any of these points affect you, speak with your doctor or pharmacist before taking Amisulprida Aurovitas.
Other medicines and Amisulprida Aurovitas
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine.
It is especially important to inform your doctor if you are taking these medicines:
Particularly, do not take this medicine and inform your doctor if you are taking:
Inform your doctor if you are taking any of the following medicines:
If you are unsure whether any of these points affect you, speak with your doctor or pharmacist before taking amisulpride.
Taking Amisulprida Aurovitas with food, drinks and alcohol
Swallow the amisulpride tablets with plenty of water before meals.
Do not drink alcohol while taking amisulpride, as this medicine may enhance the effects of alcohol.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Amisulpride is not recommended during pregnancy or in fertile women who do not use contraceptive methods.
The following symptoms have been reported in newborn babies of mothers taking amisulpride during the third trimester of pregnancy (last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing difficulties, feeding difficulties.
If your baby develops any of these symptoms, you should contact your doctor.
Breastfeeding
You should not breastfeed while taking amisulpride. Consult your doctor about the best way to feed your baby if you are taking amisulpride.
Fertility
Fertility has been observed to be decreased.
Driving and using machines
You may have blurred vision, feel less alert, drowsy or sleepy while taking this medicine. If this happens, do not drive or use tools or machines.
Amisulprida Aurovitas contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult him before taking this medicine.
Amisulprida Aurovitas contains sodium
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
How to take Amisulprida Aurovitas
Recommended dose
The amount you take of amisulprida will depend on your condition. Follow your doctor's instructions carefully.
Adults
Advanced age(patients over 65 years)
Patients with kidney problems
Children under 18 years
The safety and efficacy of amisulprida have not been established in children and adolescents under 18 years. If necessary, treatment in adolescents between 15 and 18 years should be initiated and carried out by a doctor experienced in treating schizophrenia in this age group.
Children and adolescents under 15 years should not take these tablets (see section 2 'Do not take Amisulprida Aurovitas').
If you take more Amisulprida Aurovitas than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
You may experience symptoms such as: feeling restless or agitated, muscle stiffness, feeling dizzy or drowsy, which may lead to loss of consciousness.
If you forget to take Amisulprida Aurovitas
If you forget to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Amisulprida Aurovitas
Continue taking amisulprida until your doctor tells you to. Do not stop taking this medication just because you feel better. If you stop taking it, your condition may worsen or symptoms may return. Unless your doctor tells you otherwise, amisulprida should not be stopped abruptly. Sudden discontinuation of treatment may cause withdrawal symptoms such as:
To avoid these effects, it is essential to reduce the dose gradually following your doctor's instructions.
Blood tests
Amisulprida may affect the results of some blood tests. This includes tests to measure a hormone called prolactin, and liver function tests. If you are to have a blood test, inform your doctor that you are taking amisulprida.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Stop taking Amisulprida Aurovitas and see a doctor or go to the hospital immediately if:
Rare: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Inform your doctor as soon as possible if you experience any of the following side effects:
Very common: (may affect more than 1 in 10 people)
Common: (may affect up to 1 in 10 people)
Rare: (may affect up to 1 in 100 people)
Other side effects include:
Common: (may affect up to 1 in 10 people)
Rare: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Unknown: (frequency cannot be estimated from available data)
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Stop taking Amisulprida Aurovitas and see a doctor or go to the hospital immediately if:
Rare: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Inform your doctor as soon as possible if you experience any of the following side effects:
Very common: (may affect more than 1 in 10 people)
Common: (may affect up to 1 in 10 people)
Rare: (may affect up to 1 in 100 people)
Other side effects include:
Common: (may affect up to 1 in 10 people)
Rare: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Unknown: (frequency cannot be estimated from available data)
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of packaging and medications you no longer need. This will help protect the environment.
Composition of Amisulprida Aurovitas
Each tablet contains 100 mg of amisulpride.
Appearance of the product and contents of the packaging
Tablet.
White to off-white, uncoated, round tablets (9.5 mm in diameter), with a dividing line on one side and the mark ‘L 74’ on the other side. The tablet can be divided into equal doses.
Amisulprida Aurovitas is available in PVC transparent-Aluminium and PVC/PVdC transparent-Aluminium blister packs.
Packaging sizes: 12, 20, 30, and 60 tablets.
Only some packaging sizes may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Responsible for manufacturing
APL Swift Services (Malta) Limited
HF26, Half Far Industrial Estate, Hal Far,
Birzebbuggia, BBG 3000
Malta
This medicine is authorized in the member states of the European Economic Area with the following names:
Italy:Amisulpride Aurobindo
Portugal:Amissulprida Aurovitas
Spain:Amisulprida Aurovitas 100mg tablets EFG
Last review date of this leaflet:February 2023
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.